Antidepressant-induced weight gain
Pro Research Analysisby 
Searched over 200M research papers
Antidepressant-Induced Weight Gain: Prevalence and Clinical Impact
Weight gain is a common side effect of many antidepressant medications, affecting both short-term and long-term users. This side effect can lead to health complications, reduced treatment adherence, and increased risk of obesity-related illnesses such as diabetes and heart disease Russ1988Alonso-Pedrero2019Serretti2010+2 MORE. The prevalence of significant weight gain (often defined as a 5% or greater increase from baseline) among antidepressant users is well-documented, with some studies reporting rates as high as 55% Alonso-Pedrero2019Uguz2014.
Differences in Weight Gain Among Antidepressant Classes
Tricyclic Antidepressants (TCAs)
Tricyclic antidepressants, such as amitriptyline, nortriptyline, and desipramine, are consistently associated with significant weight gain. Amitriptyline, in particular, leads to the greatest weight increase among TCAs, while nortriptyline and desipramine cause somewhat less but still notable weight gain Fernstrom1988Fava2000Serretti2010+2 MORE.
Selective Serotonin Reuptake Inhibitors (SSRIs)
SSRIs show variable effects on weight. Paroxetine is more likely to cause weight gain, especially with long-term use, while fluoxetine is associated with weight loss in the short term but may not prevent weight gain over longer periods Petimar2024Fava2000Alonso-Pedrero2019+2 MORE. Other SSRIs, such as citalopram, escitalopram, and sertraline, are also linked to weight gain, though the amount is generally less than with TCAs Petimar2024Alonso-Pedrero2019Serretti2010+1 MORE.
Other Antidepressants
Mirtazapine and duloxetine are associated with higher risks of weight gain, similar to some SSRIs and TCAs Petimar2024Fava2000Alonso-Pedrero2019+2 MORE. In contrast, bupropion is consistently linked to weight loss or the least amount of weight gain among commonly prescribed antidepressants Petimar2024Fava2000Alonso-Pedrero2019+1 MORE.
Mechanisms and Contributing Factors
The mechanisms behind antidepressant-induced weight gain are not fully understood but may involve changes in appetite regulation, metabolism, and anti-histaminergic activity Salvi2018Russ1988Serretti2010+2 MORE. Individual factors such as lower baseline body mass index, lower education status, and family history of obesity can increase the risk of significant weight gain during antidepressant therapy .
Clinical Management and Considerations
Weight gain is a key factor in noncompliance with antidepressant treatment. Clinicians are encouraged to consider the potential for weight gain when selecting an antidepressant, especially for patients at risk of obesity or related health issues Petimar2024Fava2000Alonso-Pedrero2019+2 MORE. Bupropion and nefazodone may be preferred options for patients concerned about weight gain, while drugs like amitriptyline, mirtazapine, and paroxetine should be used with caution in these populations Petimar2024Fava2000Alonso-Pedrero2019+1 MORE.
Conclusion
Antidepressant-induced weight gain is a significant and common side effect, with the degree of weight change varying widely among different medications. TCAs, mirtazapine, and some SSRIs (notably paroxetine) are most likely to cause weight gain, while bupropion is associated with weight loss or minimal gain. Understanding these differences can help guide treatment choices and improve patient outcomes.
Sources and full results
Most relevant research papers on this topic